Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
William Greene
AddedMar 31, 2024
UpdatedMay 31, 2026
William Greene

William Greene

Co-Founder, Pear Therapeutics

CrunchbaseLinkedIn

William Greene's Career

Pear Therapeutics
Pear Therapeutics

Boston, MA, US

Co-Founder
Fountain Therapeutics
Fountain Therapeutics

Stanford, CA, US

CEO· C-Suite · Management
Global Health Investment Fund
Global Health Investment Fund

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

William Greene's Career

Pear Therapeutics
Pear Therapeutics
Public$409M2002013Boston, MA, US
Co-Founder

Leadership at Pear Therapeutics

Zack LynchZack LynchBoard Member
Eric LeuthardtEric LeuthardtBoard Member
Andy SchwabAndy SchwabBoard Member
Stephen SmithStephen SmithCo-Founder
Corey McCannCorey McCannCo-Founder
Fountain Therapeutics
Fountain Therapeutics
Series A$26M372018Stanford, CA, US
CEO· C-Suite · Management

Leadership at Fountain Therapeutics

Thomas RandoThomas RandoBoard Member
Peter DiamandisPeter DiamandisBoard Member
Joseph RodgersJoseph RodgersCo-Founder

Similar to Fountain Therapeutics

Retro BiosciencesRetro BiosciencesSan Francisco, CA, USTherapeuticsest. 2021Retro BiosciencesSan Francisco, CA, US · est. 2021

Retro Biosciences, an American medical firm, pioneers in cellular reprogramming and plasma-inspired therapeutics.

Late Stage Private · $180M44
Fountain LifeFountain LifeNaples, FL, USDiagnostics, HealthTechest. 2019Fountain LifeNaples, FL, US · est. 2019

Fountain Life: Integrated health tech provider for predictive, personalized, data-driven care.

Series B · $17.1M125
Deciduous TherapeuticsDeciduous TherapeuticsSan Francisco, CA, USTherapeuticsest. 2018Deciduous TherapeuticsSan Francisco, CA, US · est. 2018

Deciduous Therapeutics: Innovating immune-modulatory therapies to remove senescent cells, improving health-span and treating age-related diseases.

Seed · $16.5M37
Dorian therapeuticsDorian therapeuticsSan Carlos, CA, USAnti-Aging, Therapeuticsest. 2018Dorian therapeuticsSan Carlos, CA, US · est. 2018

Developing senoblockers for anti-aging, Dorian Therapeutics reactivates tissue regeneration.

Acquired · $120k
Global Health Investment Fund
Global Health Investment Fund
Investment FirmInvestment Firm72012New York City, NY, US
Board Member· Board

Leadership at Global Health Investment Fund

Jonathan DeanJonathan DeanBoard Member

William Greene's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · Dunamu

People Similar to William Greene

Bill GreeneBill GreeneBoard Member · NeovistaDan PiacquadioDan PiacquadioFounder · TherapeuticsMichael DetmerMichael DetmerCo-Founder · Innovative TherapeutixChase GarrettChase GarrettCEO · Icon SourceJohn KramerJohn KramerCEO · Icon InternationalJohn BoyceJohn BoyceFounder · TigerGene